Literature DB >> 20159214

Health-related quality-of-life profiles in nonalexithymic and alexithymic subjects from general population.

Aino K Mattila1, Samuli I Saarni, Erkki Alanen, Jouko K Salminen, Erkki Kronholm, Antti Jula, Harri Sintonen, Matti Joukamaa.   

Abstract

OBJECTIVE: Earlier studies have shown an association between alexithymia and health-related quality of life (HRQoL). There has been some controversy as to whether this is attributable solely to psycho-social domains of HRQoL or also to physical domains. Furthermore, there are no studies on HRQoL profiles in representative general population samples controlling for sociodemographic variables, mental health and somatic health.
METHODS: The study forms part of the Health 2000 Study. Altogether 5090 participants from general population, aged 30-97 years, filled in the 20-item Toronto Alexithymia Scale and the 15D HRQoL scale. Depressive and anxiety disorders were assessed in a structured psychiatric interview. Physical health was examined by physicians. The 15-dimension HRQoL profiles of both alexithymic and non-alexithymic subjects were obtained by analysis of covariance, controlling for sociodemographic and health-related variables.
RESULTS: The alexithymic group had significantly (P<.001) lower mean scores on every dimension of the 15D even after controlling for confounding demographic variables, somatic diagnoses and depressive and anxiety disorders. The differences were greatest in the psycho-social domains.
CONCLUSIONS: Alexithymia seems to be a personality trait with a statistically significant association to every dimension of HRQoL, not only to psychosocial domains. However, the associations between alexithymia and some somatic dimensions may be of little clinical significance. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20159214     DOI: 10.1016/j.jpsychores.2009.09.010

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  8 in total

1.  Alexithymia and posttraumatic stress disorder following asthma attack.

Authors:  Man Cheung Chung; Natalie Wall
Journal:  Psychiatr Q       Date:  2013-09

2.  Alexithymia and its impact on quality of life in a group of Brazilian women with migraine without aura.

Authors:  Rebeca Veras de Andrade Vieira; Daniel Chaves Vieira; William Barbosa Gomes; Gustavo Gauer
Journal:  J Headache Pain       Date:  2013-02-25       Impact factor: 7.277

3.  Alexithymia and emotional regulation: A cluster analytical approach.

Authors:  Jie Chen; Ting Xu; Jin Jing; Raymond C K Chan
Journal:  BMC Psychiatry       Date:  2011-02-23       Impact factor: 3.630

4.  The relationship of Alexithymia with anxiety-depression-stress, quality of life, and social support in Coronary Heart Disease (A psychological model).

Authors:  Zohreh Khayyam Nekouei; Hamid Taher Neshat Doost; Alireza Yousefy; Gholamreza Manshaee; Masoumeh Sadeghei
Journal:  J Educ Health Promot       Date:  2014-06-23

5.  Alexithymia and psychopathological symptoms in adolescent outpatients and mothers suffering from migraines: a case control study.

Authors:  Rita Cerutti; Carmela Valastro; Samuela Tarantino; Massimiliano Valeriani; Noemi Faedda; Valentina Spensieri; Vincenzo Guidetti
Journal:  J Headache Pain       Date:  2016-04-19       Impact factor: 7.277

6.  Effect of cognitive behavioral stress management program on psychosomatic patients' quality of life.

Authors:  Zahra Ghazavi; Esmat Rahimi; Mohsen Yazdani; Hamid Afshar
Journal:  Iran J Nurs Midwifery Res       Date:  2016 Sep-Oct

7.  Alexithymia Is Associated with Reduced Quality of Life and Increased Caregiver Burden in Parkinson's Disease.

Authors:  Martin Klietz; Theresa Schnur; Simon C Drexel; Florian Lange; Lejla Paracka; Meret K Huber; Dirk Dressler; Günter U Höglinger; Florian Wegner
Journal:  Brain Sci       Date:  2020-06-24

8.  The role of alexithymia and autistic traits in predicting quality of life in an online sample.

Authors:  David Mason; Francesca Happé
Journal:  Res Autism Spectr Disord       Date:  2022-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.